These findings underscore the potential significance of specific genetic variants in the CYP1A2 gene in the etiology and progression of bladder cancer, suggesting that these polymorphisms may serve as genetic markers for assessing BLCA risk and warranting further investigation into their role in cancer development. Here, CYP1A2 is linked to urinary bladder cancer.